Validation of novel and accelerated sequences in cranial magnetic resonance imaging

Validation of novel and accelerated sequences in cranial magnetic resonance imaging - EPI DRB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032397

Enrollment

100

Registered

2023-10-30

Start date

2023-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy G40

Interventions

Group 1: Patients with known cortical dysplasia. Group 2: Patients with known hippocampal sclerosis Group 3: Control group 1 Patient collective with known epilepsy without known lesions Group 4: Contr

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Subjects: -Healthy adults, informed consent. Patients: - Informed consent. -Presence of any of the following criteria: known focal dysplasia, known hippocampal sclerosis, epilepsy without known lesion.

Exclusion criteria

Exclusion criteria: - MRI Contraindication - Pregnancy / Lactation - claustrophobia

Design outcomes

Primary

Measure	Time frame
Assessment of accelerated sequences in terms of their technical sophistication and information content with respect to the detection of focal cortical dysplasia (FCD) and hippocampal sclerosis (HS)	—

Secondary

Measure	Time frame
- Applicability of the technique in the clinical setting. - How robust are the sequences when used in sick patients with potentially reduced compliance	—

Countries

Germany

Contacts

Public ContactArne Estler

Diagn und Interv Neuroradiologie, Uniklinikum Tübingen

arne.estler@med.uni-tuebingen.de+49 7071 29 68487

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026